Recursion Pharmaceuticals, Inc. (RXRX)

4.665 +0.26 (+6.02%) USD  |  NASDAQ  |  Jan 21, 14:45
More

Recursion Pharmaceuticals Net Total Long Term Debt (Quarterly)

Net Total Long Term Debt (Quarterly) Chart

View Net Total Long Term Debt (Quarterly) for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Total Long Term Debt (Quarterly) Range, Past 5 Years

View Net Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Total Long Term Debt (Quarterly) Benchmarks

View Net Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Hims & Hers Health, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade